AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PALISADE BIO, INC. Director's Dealing 2010

Jan 4, 2010

35274_dirs_2010-01-04_d54fc24b-feae-4bd0-9d53-9d1318aa2252.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2009-12-30

Reporting Person: GARR RICHARD (CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-12-30	Common Stock	P	189111	$1.65	Acquired	1413195	Direct

Footnotes

F1: The shares were issued in consideration for the payment of reporting person's deferred 2008 bonus in the amount of $312,033.
The shares are subject to resale restrictions and may not be sold until such time as: (i) Reporting Person is no longer an
employee of the Issuer, or (ii) the occurance of a change in control of the Issuer.